Catherine M Burzik - Net Worth and Insider Trading
Catherine M Burzik Net Worth
The estimated net worth of Catherine M Burzik is at least $3 Million dollars as of 2024-11-08. Catherine M Burzik is the Director of Becton Dickinson & Co and owns about 10,007 shares of Becton Dickinson & Co (BDX) stock worth over $2 Million. Catherine M Burzik is the Senior Vice President of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA and owns about 23,416 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) stock worth over $538,100. Catherine M Burzik is also the Director of Orthofix Medical Inc and owns about 7,947 shares of Orthofix Medical Inc (OFIX) stock worth over $144,794. Details can be seen in Catherine M Burzik's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Catherine M Burzik has not made any transactions after 2021-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Catherine M Burzik
Catherine M Burzik Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine M Burzik owns 4 companies in total, including Haemonetics Corp (HAE) , Becton Dickinson & Co (BDX) , and Veradigm Inc (MDRX) among others .
Click here to see the complete history of Catherine M Burzik’s form 4 insider trades.
Insider Ownership Summary of Catherine M Burzik
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HAE | Haemonetics Corp | 2016-10-25 | director |
| BDX | Becton Dickinson & Co | 2022-01-25 | director |
| MDRX | Veradigm Inc | 2011-10-25 | director |
 | | 2021-11-19 | director |
Catherine M Burzik Latest Holdings Summary
Catherine M Burzik currently owns a total of 3 stocks. Among these stocks, Catherine M Burzik owns 10,007 shares of Becton Dickinson & Co (BDX) as of April 17, 2019, with a value of $2 Million and a weighting of 76.89%. Catherine M Burzik owns 23,416 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) as of August 2, 2006, with a value of $538,100 and a weighting of 18.21%. Catherine M Burzik also owns 7,947 shares of Orthofix Medical Inc (OFIX) as of November 19, 2021, with a value of $144,794 and a weighting of 4.9%.
Latest Holdings of Catherine M Burzik
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BDX | Becton Dickinson & Co | 2019-04-17 | 10,007 | 227.11 | 2,272,690 |
| ABI | Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA | 2006-08-02 | 23,416 | 22.98 | 538,100 |
| OFIX | Orthofix Medical Inc | 2021-11-19 | 7,947 | 18.22 | 144,794 |
Holding Weightings of Catherine M Burzik
Catherine M Burzik Form 4 Trading Tracker
According to the SEC Form 4 filings, Catherine M Burzik has made a total of 0 transactions in Becton Dickinson & Co (BDX) over the past 5 years. The most-recent trade in Becton Dickinson & Co is the sale of 45 shares on April 17, 2019, which brought Catherine M Burzik around $10,037.
According to the SEC Form 4 filings, Catherine M Burzik has made a total of 0 transactions in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) over the past 5 years. The most-recent trade in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA is the sale of 668 shares on August 2, 2006, which brought Catherine M Burzik around $21,590.
According to the SEC Form 4 filings, Catherine M Burzik has made a total of 1 transactions in Orthofix Medical Inc (OFIX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Orthofix Medical Inc is the acquisition of 1,660 shares on November 19, 2021, which cost Catherine M Burzik around $50,248.
Insider Trading History of Catherine M Burzik
- 1
Catherine M Burzik Trading Performance
GuruFocus tracks the stock performance after each of Catherine M Burzik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine M Burzik is 2.95%. GuruFocus also compares Catherine M Burzik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine M Burzik within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catherine M Burzik's insider trading performs compared to the benchmark.
Performance of Catherine M Burzik
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.61 | | | | | |
| Relative Return to S&P 500(%) | -3.26 | | | | | |
Catherine M Burzik Ownership Network
Ownership Network List of Catherine M Burzik
Ownership Network Relation of Catherine M Burzik
Catherine M Burzik Owned Company Details
What does Haemonetics Corp do?
Who are the key executives at Haemonetics Corp?
Catherine M Burzik is the director of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP and General Counsel Michelle L Basil .
Haemonetics Corp (HAE) Insider Trades Summary
Over the past 18 months, Catherine M Burzik made no insider transaction in Haemonetics Corp (HAE). Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 17,354 shares made by Stewart W Strong , a net sale of 9,129 shares made by Anila Lingamneni , and a net sale of 16,652 shares made by Michelle L Basil .
In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,857 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,857 shares.
Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Haemonetics Corp Insider Transactions
Catherine M Burzik Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine M Burzik. Currently GuruFocus does not have mailing address information for Catherine M Burzik.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
